mynth
11/2010MajorityLBO

Ardian takes majority stake in Novacap

FRANCE Chemicals & Materials / Specialty Chemicals EV €300–700M

Context

Ardian (then AXA Private Equity) entered into a definitive agreement to acquire a majority stake in Novacap from the private equity firm Bain Capital. The transaction marked the second major LBO for the chemical group since its carve-out from Rhodia in 2003. The strategic rationale for Ardian centered on transforming a primarily French-centric industrial producer into a global specialty chemical platform. The investment plan focused on two main pillars: accelerating international expansion and diversifying the product mix toward high-growth pharmaceutical and health markets. This transition aimed to reduce the group's exposure to cyclical commodity chemicals in favor of more stable, high-margin specialty ingredients.

By taking control of Novacap, Ardian continues its expansion strategy. Previously, the group had completed 2 acquisitions, including Diana Group in 2007.

Novacap, which reported an EBITDA margin of [members only] in 2010, is valued in this transaction at an EV/EBITDA multiple of 5x–12x.

-> Deep-dive in Industry & Manufacturing market trends

Target

Novacap is an international specialty chemicals group headquartered in Lyon, France, specializing in the production and distribution of essential chemical ingredients. The organization is a global leader across diversified end-markets, including pharmaceuticals, healthcare, cosmetics, fragrances, food, animal nutrition, and environmental services. Its extensive product portfolio includes active pharmaceutical ingredients (APIs) such as aspirin and paracetamol, as well as salicylic acid, soda ash, sodium bicarbonate, and oxygenated solvents. The business model transitioned from a France-centric operation to a global platform with 14 production facilities worldwide and a workforce of 1,600 people, half of whom are based in Asia. Organized into three divisions—Mineral Specialties, Pharmaceutical & Cosmetics, and Performance Chemicals—the group serves over 750 clients globally, emphasizing sustainable development and high-value chemical synthesis for mission-critical consumer products.

Ent. Value

€300–700M

Equity Value

[members only]

Multiples

EV / Revenue

below 1.5x

EV / EBITDA

5x–12x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2010
€250–500M
€25–50M
[members only]
2009
€250–500M
€25–50M
[members only]

Other operations with Novacap

Other operations with Novacap
DateAcquirerTargetCountrySector
04/2016EURAZEO / MERIEUX EQUITY PARTNERSNOVACAPFRANCESpecialty Chemicals

Other operations with Ardian

Other operations with Ardian
DateAcquirerTargetCountrySector
07/2016ARDIANDEDALUSITALYHealthcare
06/2016ARDIANDIAMFRANCEMarketing & Events
04/2016ARDIANTRIGOFRANCETIC (Testing, Inspection, Certification)
10/2015ARDIANSOLINA GROUPFRANCEIngredients
07/2015ARDIANIRCAITALYIngredients
02/2015ARDIANSIACI SAINT-HONOREFRANCEBrokerage
01/2014ARDIANNHV GROUPBELGIUMTransport & Logistics
10/2013ARDIANLABORATOIRES ANIOSFRANCEMedical Consumables
06/2007ARDIANDIANA GROUPFRANCEIngredients
10/2006ARDIANGERFLORFRANCEFlooring

Similar deals in Chemicals & Materials

Similar deals in Chemicals & Materials
DateAcquirerTargetCountrySector
04/2014MBO+COSMOGENFRANCEPackaging & Containers
02/2014AUTAJONFINCARTAITALYPaper & Cardboard
12/2013ASTORGKERNEOSFRANCEConstruction Materials
06/2013CINVENCERAMTECGERMANYGlass & Ceramics
11/2011DENTRESSANGLECHEMICAFRANCEPlastics
02/2011ICGGERFLORFRANCEFlooring
01/2010OAKTREE CAPITAL MANAGEMENTVERESCENCEFRANCEGlass Packaging
10/2006ARDIANGERFLORFRANCEFlooring
01/2006WENDELMATERISLUXEMBOURGConstruction Materials
09/2003LBO FRANCEMATERISLUXEMBOURGConstruction Materials

REFERENCES

Valuation range: EV €300–700M

Revenue range: €250–500M

EBITDA range: €25–50M

EV/Revenue range: below 1.5x

EV/EBITDA range: 5x - 12x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Novacap by Ardian are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers the acquisition of a majority stake in Novacap, a French company specialised in Specialty Chemicals, by Ardian in 2010, structured as a leveraged buyout (LBO). Ownership has since evolved, leading to a subsequent transaction with Eurazeo / Merieux Equity Partners in April 2016 (see the dedicated deal page for details).

How was the acquisition of Novacap by Ardian valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €300–700M band, its EV/EBITDA multiple within the 5x - 12x range, and its EV/revenue multiple within the below 1.5x range. Exact figures are available to members.

What were Novacap’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Novacap generated annual revenue estimated in the €250–500M range and EBITDA in the €25–50M bracket (FY 2010). Detailed financial figures are available to members.

What sources support the information on this transaction?

Transaction intelligence is supported by independent reporting from specialized financial publications, alongside a private document shared by the community and verified by the mynth team to ensure the accuracy of the shared information.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.